EU drug regulator to review Eli Lilly and Incyte arthritis drug for use in Covid-19 patients on oxygen ...News

The European Medicines Agency (EMA) said it will conduct an accelerated assessment of the arthritis drug Olumiant made by Eli Lilly and Incyte Corp to see if it can be rolled out to treat hospitalized Covid-19 patients on oxygen. The plan is to repurpose the drug for use in people over the age of 10 as a potential treatment to help reduce the inflammation and tissue damage associated with severe Covid-19 infections. The review will assess the results from two large randomized studies in patients being treated for the virus, the agency said in a statement on Thursday. Also on rt.com

Read More Details
Finally We wish PressBee provided you with enough information of ( EU drug regulator to review Eli Lilly and Incyte arthritis drug for use in Covid-19 patients on oxygen )

Also on site :

• Lou Christie, “Lightnin’ Strikes” and “Rhapsody in the Rain” Singer, Dies at 82
• Bruce Springsteen Hints at New Music and Reveals Upcoming Box Set
• Detained Afghan’s legal entry into U.S. was ‘improvident,’ government argues